Sustainability at the Heart of Aptar Pharma’s Expansion

Summary

Sustainability is central to AptarGroup’s business operations, earning it high ratings in Forbes, Time Magazine, and USA Today as a great place to work. The company actively participates in global sustainability efforts, including the United Nations Global Compact and the Ellen MacArthur Foundation’s New Plastics Economy. Aptar Pharma is a leader in developing sustainable drug delivery systems through the Futurity^® platform, which aims at reducing the impact of drug delivery solutions on the environment. The organization is committed to making its manufacturing processes environmentally friendly by reducing waste, conserving energy, and fostering inclusivity and equity in the workplace.

Injection devices and primary packaging cannot enter be recycled as they are classified as biohazardous waste. In order to make our Injectables products more sustainable, Aptar Pharma focused on making its manufacturing more sustainable. All Injectables sites are certified Landfill Free through Aptar’s internal program, with 90%+ of the vulcanized rubber scraps being recycled. To go further, Aptar Pharma dedicated projects followed a procedure improve energy efficiency in our manufacturing sites:

• Establishing comprehensive energy assessments at the site level
• Promoting an energy-saving culture in factories with short-term action plans to reduce superfluous energy expenditure;
• Identifying long-term energy-saving opportunities and prioritize high-impact investments in partnership with third-party organizations
• Implementing new technologies and modernizing utilities to improve energy efficiency.

As a result, Aptar Pharma reduced energy consumption by 99.7% for building heating and by 15% for WFI production in our Granville site, which reduces the carbon footprint of our manufacturing.

In addition to the upgrade of existing manufacturing sites, Aptar Pharma’s global expansion program includes the building of a new 19,000m² site dedicated to vial and pre-filled syringe components manufacturing. Learning from our previous energy-saving initiative, our facility was built to optimize energy consumption. This facility also features solar panels, rainwater collection, and ergonomic work equipment to promote well-being at work. All these sustainability initiatives were recognised by the US Green Building Council’s Leadership in Energy and Environmental Design (LEED) rating system with the silver certification.

Beyond manufacturing, Aptar continues to develop internal expertise in conducting drug product Life Cycle Assessments. Whether it is by working on new product designs, sourcing of raw materials or mass balance approaches, we are committed to reducing our impact on the environment so that we can continue to deliver life-saving solutions to patients around the world responsibly.